Chrome Extension
WeChat Mini Program
Use on ChatGLM

Moving towards a comprehensive heart failure management beyond ejection fraction

European journal of heart failure(2023)

Cited 0|Views3
No score
Abstract
European Journal of Heart FailureEarly View Invited Editorial Moving towards a comprehensive heart failure management beyond ejection fraction Matteo Pagnesi, Matteo Pagnesi Institute of Cardiology, ASST Spedali Civili, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, Brescia, ItalySearch for more papers by this authorLisa Serafini, Lisa Serafini Institute of Cardiology, ASST Spedali Civili, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, Brescia, ItalySearch for more papers by this authorMarianna Adamo, Corresponding Author Marianna Adamo [email protected] Institute of Cardiology, ASST Spedali Civili, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, Brescia, Italy Corresponding author. Institute of Cardiology, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, Piazzale Spedali Civili 1, 25123 Brescia, Italy. Fax: +39 030 3700359, Email: [email protected]Search for more papers by this author Matteo Pagnesi, Matteo Pagnesi Institute of Cardiology, ASST Spedali Civili, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, Brescia, ItalySearch for more papers by this authorLisa Serafini, Lisa Serafini Institute of Cardiology, ASST Spedali Civili, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, Brescia, ItalySearch for more papers by this authorMarianna Adamo, Corresponding Author Marianna Adamo [email protected] Institute of Cardiology, ASST Spedali Civili, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, Brescia, Italy Corresponding author. Institute of Cardiology, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, Piazzale Spedali Civili 1, 25123 Brescia, Italy. Fax: +39 030 3700359, Email: [email protected]Search for more papers by this author First published: 02 August 2023 https://doi.org/10.1002/ejhf.2987 The opinions expressed in this article are not necessarily those of the Editors of the European Journal of Heart Failure or of the European Society of Cardiology. doi: 10.1002/ejhf.2948. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. References 1McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Eur J Heart Fail 2022; 24: 4–131. https://doi.org/10.1002/ejhf.2333 2Girerd N, Mewton N, Tartière J, Guijarro D, Jourdain P, Damy T, et al. Practical outpatient management of worsening chronic heart failure. Eur J Heart Fail 2022; 24: 750–761. https://doi.org/10.1002/ejhf.2503 3Koehler F, Koehler K, Deckwart O, Prescher S, Wegscheider K, Kirwan B-A, et al. Efficacy of telemedical interventional management in patients with heart failure (TIM-HF2): A randomised, controlled, parallel-group, unmasked trial. Lancet 2018; 392: 1047–1057. https://doi.org/10.1016/S0140-6736(18)31880-4 4Angermann CE, Assmus B, Anker SD, Asselbergs FW, Brachmann J, Brett M, et al.; MEMS-HF Investigators. Pulmonary artery pressure-guided therapy in ambulatory patients with symptomatic heart failure: The CardioMEMS European Monitoring Study for Heart Failure (MEMS-HF). Eur J Heart Fail 2020; 22: 1891–1901. https://doi.org/10.1002/ejhf.1943 5Brugts JJ, Radhoe SP, Clephas PRD, Aydin D, van Gent MWF, Szymanski MK, et al.; MONITOR-HF investigators. Remote haemodynamic monitoring of pulmonary artery pressures in patients with chronic heart failure (MONITOR-HF): A randomised clinical trial. Lancet 2023; 401: 2113–2123. https://doi.org/10.1016/S0140-6736(23)00923-6 6Bellicini MG, D'Altilia FP, Gussago C, Adamo M, Lombardi CM, Tomasoni D, et al. Telemedicine for the treatment of heart failure: New opportunities after COVID-19. J Cardiovasc Med (Hagerstown). https://doi.org/10.2459/JCM.0000000000001514 Published online ahead of print 27/06/23. 7Anker SD, Butler J, Filippatos G, Ferreira JP, Bocchi E, Böhm M, et al.; EMPEROR-Preserved Trial Investigators. Empagliflozin in heart failure with a preserved ejection fraction. N Engl J Med 2021; 385: 1451–1461. https://doi.org/10.1056/NEJMoa2107038 8Solomon SD, McMurray JJV, Claggett B, de Boer RA, DeMets D, Hernandez AF, et al.; DELIVER Trial Committees and Investigators. Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction. N Engl J Med 2022; 387: 1089–1098. https://doi.org/10.1056/NEJMoa2206286 9Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, et al. 2022 AHA/ACC/HFSA guideline for the management of heart failure: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 2022; 145: e895–e1032. https://doi.org/10.1161/CIR.0000000000001063 10Pagnesi M, Butler J, Metra M. Ejection fraction in heart failure: Just become Emperor's new clothes? Eur J Heart Fail 2022; 24: 351–352. https://doi.org/10.1002/ejhf.2399 11Redfield MM, Borlaug BA. Heart failure with preserved ejection fraction. JAMA 2023; 329: 827–838. https://doi.org/10.1001/jama.2023.2020 12Kerwagen F, Koehler K, Vettorazzi E, Stangl V, Koehler M, Halle M, et al. Remote patient management of heart failure across the ejection fraction spectrum: A pre-specified analysis of the TIM-HF2 trial. Eur J Heart Fail. https://doi.org/10.1002/ejhf.2948 Published online ahead of print 27/06/23. 13Pagnesi M, Metra M, Cohen-Solal A, Edwards C, Adamo M, Tomasoni D, et al. Uptitrating treatment after heart failure hospitalization across the spectrum of left ventricular ejection fraction. J Am Coll Cardiol 2023; 81: 2131–2144. https://doi.org/10.1016/j.jacc.2023.03.426 14Sydow H, Prescher S, Koehler F, Koehler K, Dorenkamp M, Spethmann S, et al. Cost-effectiveness of noninvasive telemedical interventional management in patients with heart failure: Health economic analysis of the TIM-HF2 trial. Clin Res Cardiol 2022; 111: 1231–1244. https://doi.org/10.1007/s00392-021-01980-2 Early ViewOnline Version of Record before inclusion in an issue ReferencesRelatedInformation
More
Translated text
Key words
comprehensive heart failure management,heart failure,ejection fraction
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined